Regeneron blows past third-quarter earnings estimates and says has shared COVID-19 vaccine data with FDAMarket Watch • 11/05/20
Why the Earnings Surprise Streak Could Continue for Regeneron (REGN)Zacks Investment Research • 11/03/20
GM, PayPal, Qualcomm, Regeneron, Uber and More Major Earnings Coming This Week24/7 Wall Street • 11/01/20
Why Regeneron Is Halting Coronavirus Antibody Cocktail Study Enrollment In Patients With Severe CasesBenzinga • 10/30/20
REGN-COV2 Independent Data Monitoring Committee Recommends Holding Enrollment in Hospitalized Patients with High Oxygen Requirements and Continuing Enrollment in Patients with Low or No Oxygen RequirementsPRNewsWire • 10/30/20
Regeneron says IDMC recommends halt of some REGN-COV2 trial enrollment for safety risksMarket Watch • 10/30/20
Regeneron's Immunotherapy Is Given Priority Review for Treatment of New Lung Cancer PatientsThe Motley Fool • 10/29/20
Regeneron Once Again Earns #1 Ranking in Science Magazine's Top Biopharma Companies to Work ForPRNewsWire • 10/29/20
European Patent Office rules in favor of Sanofi and Regeneron concerning Praluent® (alirocumab)GlobeNewsWire • 10/29/20
Regeneron Posts Positive Data For Covid-19 Treatment; Lung Cancer Drug AdvancesInvestors Business Daily • 10/29/20
Regeneron Says COVID-19 Antibody Cocktail Reduced Viral Load, Need For Medical Care In Late-Stage TrialBenzinga • 10/29/20